Immunomodulatory and antibacterial effects of cystatin 9 against Francisella tularensis

Molecular Medicine

Volumn 19, Issue 1, 2013, Pages 263-275

  Eaves Pyles, Tonyia ^a   Patel, Jignesh ^a   Arigi, Emma ^b   Cong, Yingzi ^a   Cao, Anthony ^a   Garg, Nisha ^a   Dhiman, Monisha ^a,c   Pyles, Richard B ^a   Arulanandam, Bernard ^d   Miller, Aaron L ^a   Popov, Vsevolod L ^a   Soong, Lynn ^a   Carlsen, Eric D ^a   Coletta, Ciro ^a   Szabo, Csaba ^a   Almeida, Igor C ^b  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TEXAS AT EL PASO   (United States)

^c CENTRAL UNIVERSITY OF PUNJAB   (India)

^d University of San Antonio   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; IMMUNOMODULATING AGENT; MAMMALIAN TARGET OF RAPAMYCIN; RECOMBINANT CYSTATIN 9; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIAL IMMUNITY; BACTERIAL LOAD; BACTERIAL VIABILITY; BACTERIAL VIRULENCE; CELL MIGRATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EFFECT; FEMALE; FRANCISELLA TULARENSIS; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; INFECTION PREVENTION; INNATE IMMUNITY; LUNG INFECTION; MACROAUTOPHAGY; MACROPHAGE; MOUSE; NONHUMAN; PHAGOSOME; PRIORITY JOURNAL; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; SURVIVAL RATE; TULAREMIA; UPREGULATION;

ANIMALS; ANTI-BACTERIAL AGENTS; CELL MOVEMENT; CYSTATINS; FEMALE; FRANCISELLA TULARENSIS; HUMANS; IMMUNOLOGIC FACTORS; MACROPHAGES, ALVEOLAR; MICE; MICE, INBRED BALB C; PHAGOCYTOSIS; RECOMBINANT PROTEINS; TULAREMIA; VIRULENCE;

EID: 84883257154     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/molmed.2013.00081     Document Type: Article

References (57)

1. Ochieng J, Chaudhuri G. (2010) Cystatin superfamily. J. Health Care Poor Underserved. 21:51-70.
2. Loffek S, Schilling O, Franzke C-W. (2011) Biological role of matrix metalloproteinases: a critical balance. Eur. Respir. J. 38:191-208.
3. Zavasnik-Bergant T. (2008) Cystatin protease inhibitors and immune functions. Front. Biosci. 4625-37.
4. Kopitar-Jerala. (2006) The role of cystatins in cells of the immune system. FEBS Letters. 580:6295-301.
5. Bobek LA, Levine MJ. (1992) Cystatins-inhibitors of cysteine proteinases. Crit. Rev. Oral Biol. Med. 4:307-32.
6. Vray B, Hartmann S, Hoebeke J. (2002) Immunomodulatory properties of cystatins. Cell. Mol. Life Sci. 59:1503-12.
7. Poteryaeva ON, et al. (2000) Cysteine proteinase inhibitor level in tumor and normal tissues in control and cured mice. Drugs Exp. Clin. Res. 26:301-6.
8. Yang F, et al. (2010) Cystatin B inhibition of TRAIL-induced apoptosis is associated with the protection of FLIPL from degradation by the E3 ligase itch in human melanoma cells. Cell Death Differ. 17:1354-67.
9. Briggs JJ, et al. (2010) Cystatin E/M suppresses legumain activity and invasion of human melanoma. BMC Cancer. 10:17.
10. Pirttilä TJ, et al. (2005) Cystatin C modulates neurodegeneration and neurogenesis following status epilepticus in mouse. Neurobiol. Dis. 20:241-53.
11. Gauthier S, Kaur G, Mi W, Tizon B, Levy E. (2011) Protective mechanisms by cystatin C in neurodegenerative diseases. Front. Biosci. 3:541-54.
12. Esposito E, Cuzzocrea S. (2010) New therapeutic strategy for Parkinson's and Alzheimer's disease. Curr. Med. Chem.17:2764-74.
13. Tizon B, et al. (2010) Induction of autophagy by cystatin C: a mechanism that protects murine primary cortical neurons and neuronal cell lines. PLoS One. 5(3):e9819.
14. Rivera-Rivera L, Perez-Laspiur J, Colón K, Meléndez LM. (2012) Inhibition of interferon response by cystatin B: implication in HIV replication of macrophage reservoirs. J. Neurovirol. 18:20-9.
15. Dennis, DT, et al. (2001). Tularemia as a biological weapon: Medical and public health management. JAMA. 285:2763-73.
16. Jacobs, RF. (1977) Tularemia. Ad. Ped. Infect. Dis. 12:55-69.
17. Sjöstedt A, Tärnvik A, Sandström G. (1996) Francisella tuarensis: Host-parasite interaction. FEMS Immun. Med. Micro. 13:181-4.
18. Eaves-Pyles TD, Wong HR, Odoms K, Pyles RB. (2001) Salmonella flagellin-dependent proinflammatory responses are localized to the conserved amino and carboxyl regions of the protein. J. Immunol. 167:7009-16.
19. Dhiman M, et al. (2008) Enhanced nitrosative stress during Trypanosoma cruzi infection causes nitrotyrosine modification of host proteins: implications in Chagas' disease. Am. J. Pathol. 173:728-40.
20. Bayer-Santos E, et al. (2013) Proteomic analysis of Trypanosoma cruzi secretome: characterization of two populations of extracellular vesicles and soluble proteins. J. Proteome Res. 12:883-97.
21. Gentry M, et al. (2007) Role of primary human alveolar epithelial cells in host defense against Francisella tularensis infection. Infect. Immun. 75:3969-78.
22. Coletta C, et al. (2012) Hydrogen sulfide and nitric oxide are mutually dependent in the regulation of angiogenesis and endothelium-dependent vasorelaxation. Proc. Natl. Acad. Sci. U. S. A. 109:9161-6.
23. Lu R, Popov V, Patel J, Eaves-Pyles T. (2012) Burkholderia mallei and Burkholderia pseudomallei stimulate differential inflammatory responses from human alveolar type II cells (ATII) and macrophages. Front. Cell. Infect. Microbiol. 2:165.
24. Magister S, Kos J. (2013) Cystatins in immune system. Cancer. 4:45-56.
25. Turk V, Stoka V, Turk D. (2008) Cystatins: biochemical and structural properties, and medical relevance. Front. Biosci. 13:5406-20.
26. Chang SH, et al. (2009) VEGF-A induces angiogenesis by perturbing the cathepsin-cysteine protease inhibitor balance in venules, causing basement membrane degradation and mother vessel formation. Cancer Res. 69:4537-44.
27. Clemens DL, Lee BY, Horwitz MA. (2004) Virulent and avirulent strains of Francisella tularensis prevent acidification and maturation of their phagosomes and escape into the cytoplasm in human macrophages. Infect. Immun. 72:3204-17.
28. Lindgren H, et al. (2004) Factors affecting the escape of Francisella tularensis from the phagolysosome. J. Med. Microbiol. 53:953-8.
29. Izaki K, Matsuhashi M, Strominger JL. (1966) Glycopeptide transpeptidase and D-alanine carboxypeptidase: penicillin-sensitive enzymatic reactions. PNAS. 55:656-63.
30. Rogers R, Yogum DJ, Waxman JRR, Stominger JL. (1979) Mechanism of penicillin action: Penicillin and substrate bind covalently to the same active site serine in two bacterial D-alanine carboxypeptidases. PNAS. 76:2730-4.
31. Rodriguez OC, et al. (2003) Conserved microtubule-actin interactions in cell movement and morphogenesis. Nat. Cell. Biol. 5:599-609.
32. Yuan A, Cia CP. (1999) Co-loss of profiling I, II and cofilin with actin from maturing phagosomes in Dictyostelium discoideum. Protoplasma. 209:214-225.
33. Chung S, Sundar IK, Yao H, Ho YS, Rahman I. (2010) Glutaredoxin 1 regulates cigarette smokemediated lung inflammation through differential modulation of I{kappa}B kinases in mice: impact on histone acetylation. Am. J. Physiol. Lung Cell Mol. Physiol. 299:L192-203.
34. Mor-Vaknin N, et al. (2011) Vimentin suppresses the production of reactive oxygen species and the antimicrobial response via p47phox [abstract]. Arthritis Rheum. 63 Suppl 10:1003.
35. Rogel MR, et. al. (2011) Vimentin is sufficient and required for wound repair and remodeling in alveolar epithelial cells. FASEB J. 25:3873-83.
36. Pyles RB, Jezek GE, Eaves-Pyles TD. (2010) Tolllike receptor 3 agonist protection against experimental Francisella tularensis respiratory tract infection. Infect. Immun. 78:1700-10.
37. Mohamed MM, Sloane BF. (2006) Cysteine cathepsins: multifunctional enzymes in cancer. Nature Cancer. 6:764-75.
38. Cantres-Rosario Y, et al. (2013) Cathepsin B and cystatin B in HIV-seropositive women are associated with infection and HIV-1-associated neurocognitive disorders. AIDS. 27:347-56.
39. Krawczeski CD, et al. (2010) Serum cystatin C is an early predictive biomarker of acute kidney injury after pediatric cardiopulmonary bypass. Clin. J. Am. Soc. Nephrol. 5:1552-7.
40. Hassinger AB, et al. (2012) Predictive power of serum cystatin C to detect acute kidney injury and pediatric-modified RIFLE class in children undergoing cardiac surgery. Pediatr. Crit. Care Med. 13:435-40.
41. Qing X, et al. (2012) Cystatin C and asymptomatic coronary artery disease in patients with metabolic syndrome and normal glomerular filtration rate. Cardiovasc. Diabetol. 11:108.
42. Sharma J, Mares CA, Li Q, Morris EG, Teale JM. (2011) Features of sepsis caused by pulmonary infection with Francisella tularensis Type A strain. Microb. Pathog. 51:39-47.
43. Clemens DL, Lee BY, Horwitz MA. (2004) Virulent and avirulent strains of Francisella tularensis prevent acidification and maturation of their phagosomes and escape into the cytoplasm in human macrophages. Infect. Immun. 72:3204-17.
44. Bönquist L, Lindgren H, Golovliov I, Guina T, Sjöstedt A. (2008) MglA and Igl proteins contribute to the modulation of Francisella tularensis live vaccine strain-containing phagosomes in murine macrophages. Infect. Immun. 76:3502-10.
45. Checroun C, Whrly TD, Rishcher DR, Hayes SF, Celli J. (2006) Autophagy-mediated reentry of Francisella tularensis in to the endocytic compartment after cytoplasmic replication. Proc. Natl. Acad. Sci. U. S. A. 103:14578-83.
46. Weiss DS, Henry T, Monack DM. (2007) Francisella tularensis: Activation of the inflammasome. Ann. NY Acad. Sci. 1105:219-37.
47. Jones JW, Broz P, Monack DM. (2011) Innate immune recognition of Francisella tularensis: activation of type-I interferons and the inflammasome. Front. Micro. 2:1-10.
48. Mariathasan S, Weiss DS, Dixit VM, Monack DM. (2005) Innate immunity against Francisella tularensis is dependent on the ASC/caspase-1 axis. J. Exp. Med. 202:1043-9.
49. Malik M, et al. (2007) Matrix metalloproteinase 9 activity enhances host susceptibility to pulmonary infection with type A and B strains of Francisella tularensis. J. Immunol. 178:1013-20.
50. Bosio CM, Elkins KL. (2001) Susceptibility to secondary Francisella tularensis live vaccine strain infection in B-cell-deficient mice is associated with neutrophilia but not with defects in specific T-cell-mediated immunity. Infect. Immun. 69:194-203.
51. Leavy O. (2013) Mucosal immunology: autophagy helps man the barriers. Nat. Rev. Immunol. 13:470-1.
52. Patel AS, Morse D, Choi AM. (2013) Regulation and functional significance of autophagy in respiratory cell biology and disease. Am. J. Respir. Cell Mol. Biol. 48:1-9.
53. Gong L, Devenish RJ, Prescott M. (2012) Autophagy as a macrophage response to bacterial infection. IUBMB Life. 64:740-7.
54. Jaber N, et al. (2012) Class III PI3K Vps34 plays an essential role in autophagy and in heart and liver function. Proc. Natl. Acad. Sci. U. S. A. 109:2003-8.
55. Lamouille S, Connolly E, Smyth JW, Akhurst RJ, Derynck R. (2012) TGF--induced activation of mTOR complex 2 drives epithelial-mesenchymal transition and cell invasion. J. Cell Sci. 125:1259-73.
56. Mort JS, Buttle DJ. (1997) Cathepsin B. Int. J. Biochem. Cell Biol. 29:715-20.
57. Wang L, et al. (2012) Antimicrobial activity and molecular mechanism of the CRES protein. PLoS One. 7:e48368.